Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal Sells 5,995 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal sold 5,995 shares of Viemed Healthcare stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $8.58, for a total transaction of $51,437.10. Following the sale, the director now owns 126,843 shares in the company, valued at $1,088,312.94. This represents a 4.51 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Nitin Kaushal also recently made the following trade(s):

• On Monday, November 11th, Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00.

Viemed Healthcare Stock Up 0.1 %

Shares of NASDAQ:VMD opened at $8.66 on Wednesday. Viemed Healthcare, Inc. has a 52 week low of $6.21 and a 52 week high of $10.44. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The company’s fifty day moving average is $8.51 and its 200-day moving average is $7.57. The company has a market capitalization of $337.22 million, a PE ratio of 32.07 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The company had revenue of $58.00 million for the quarter.

Institutional Investors Weigh In On Viemed Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. lifted its position in Viemed Healthcare by 5.3% during the 1st quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock worth $1,386,000 after buying an additional 7,386 shares in the last quarter. Vanguard Group Inc. lifted its position in Viemed Healthcare by 53.0% during the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock worth $16,803,000 after buying an additional 617,009 shares in the last quarter. Price T Rowe Associates Inc. MD acquired a new position in Viemed Healthcare during the 1st quarter worth about $97,000. Summit Global Investments lifted its position in Viemed Healthcare by 109.5% during the 2nd quarter. Summit Global Investments now owns 33,973 shares of the company’s stock worth $223,000 after buying an additional 17,760 shares in the last quarter. Finally, Penbrook Management LLC lifted its position in Viemed Healthcare by 236.0% during the 2nd quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock worth $1,517,000 after buying an additional 162,670 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.